LXRX · Lexicon Pharmaceuticals, Inc.

$2.32 -0.02 (-0.85%) At close · Aug 14

Market Cap

$1.03B

444.96M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-04	2026-06-30
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
8-K	2026-05-06	2026-05-04
8-K	2026-04-30	—
DEF 14A	2026-03-16	—
8-K	2026-03-05	—
10-K	2026-03-05	2025-12-31
8-K	2026-02-02	2026-01-29
8-K	2026-01-29	—
Investor Event Transcript	2025-12-31	—
8-K	2025-11-10	2025-11-06
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
Investor Event Transcript	2025-09-30	—
10-Q	2025-08-06	2025-06-30
8-K	2025-08-06	—
8-K	2025-07-28	2025-07-23
8-K	2025-07-03	—
8-K	2025-06-03	2025-06-02
10-Q	2025-05-14	2025-03-31
8-K	2025-05-13	—
DEF 14A	2025-04-22	—
8-K	2025-03-28	2025-03-27
10-K	2025-03-07	2024-12-31
8-K	2025-03-06	—
8-K	2025-01-07	2025-01-03
8-K	2025-01-02	—
8-K	2024-11-22	—
8-K	2024-11-20	2024-11-19
10-Q	2024-11-13	2024-09-30
8-K	2024-11-12	—
8-K	2024-10-16	—
8-K	2024-09-16	2024-09-13
10-Q	2024-08-02	2024-06-30
8-K	2024-08-01	—
8-K	2024-07-08	2024-07-03
8-K	2024-07-01	2024-06-28
8-K	2024-05-10	—
8-K	2024-05-02	—
10-Q	2024-05-02	2024-03-31
8-K	2024-04-29	—
DEF 14A	2024-03-26	2024-03-25
10-K	2024-03-25	2023-12-31
8-K	2024-03-12	—
8-K	2024-03-11	2024-03-06

Showing 1–50 of 126 filings

Key facts CIK 1062822 CUSIP 528872302 13F (30d) 150 filings 149 filers Visit website Investor relations